Dermatology
From the Journals
Cutaneous vasculitis curtails quality of life
Survey respondents described a generally poor health-related quality of life that was detailed as more severe with a skin-specific instrument than...
Conference Coverage
Can this tool forecast peanut allergies?
The predictive scorecard captures 14 images from one infant of mixed race, two White infants, two Black infants, and two Hispanic infants.
Latest News
Two phase 3 trials show benefits of dupilumab for prurigo nodularis
The results “support the involvement of type 2 cytokines in driving PN disease pathogenesis and the targeting of the IL-4/IL-13 axis as a novel...
Photo Rounds
Itchy pustules over hair follicles
From the Journals
Study shifts burden of IgG4-related disease to women
First population-based U.S. analysis establishes “key benchmarks” for immune-mediated condition initially described in 2001.
Latest News
1,726-nm lasers poised to revolutionize acne treatment, expert predicts
“Further study of both scarring and acne are needed to fully categorize the benefit and to optimize treatments,” Dr. Jeffrey Dover said.
Latest News
Contact allergens lurk in diabetes devices
Some reports suggest that at any given time, skin complications may affect as many as one quarter to one half of patients who use diabetes devices...
Latest News
Beware the hidden allergens in nutritional supplements
A detailed history of supplement use is important, as it may reveal possible allergens as the cause of previously unidentified reactions.
Latest News
Controlled hyperthermia: Novel treatment of BCCs without surgery continues to be refined
A novel, noninvasive technique of controlled hyperthermia and mapping protocol designed to help clinicians with margin assessment and treatment of...
Latest News
COVID-19 and psoriasis: Is there a link?
“Infection with COVID-19 has been associated with flares of guttate and pustular psoriasis, and even psoriasis that affects 100% of the skin.”
Latest News
FDA puts partial hold on investigational alopecia areata drug deuruxolitinib
The announcement came after a pulmonary embolism occurred with the 12-mg twice-daily dose in one of the long-term open-label extension studies.